Dermacyd PH_DETINBACK (Lactic Acid) Sweet Flower

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

PHASE3

Total Enrollment

53 participants

Study Classification

INTERVENTIONAL

Study Start Date

2008-07-31

Study Completion Date

2008-09-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The purpose of this study is to demonstrate the absence of irritation potential (primary dermical irritability and cumulated dermical irritability) and allergy (sensibilization) of the product Dermacyd PHDETINBACK Sweet Flower.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Dermacyd PH_DETINLYN (Lactic Acid) Sweet Flower - Compatibility

NCT00785655

Hygiene

COMPLETED PHASE3

Dermacyd PH_DETINBACK (Lactic Acid) Sweet Flower - Photo Avaluation

NCT00785720

Hygiene

COMPLETED PHASE3

Dermacyd PH_DETINLYN (Lactic Acid) Sweet Flower - Photo Evaluation.

NCT00785590

Hygiene

COMPLETED PHASE3

Dermacyd Silver Floral (Lactic Acid) - Compatibility.

NCT00933712

Hygiene

COMPLETED PHASE3

Dermacyd Silver Floral (Lactic Acid) - Compatibility - Stay on Floral

NCT00933504

Hygiene

COMPLETED PHASE3

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Hygiene

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NON_RANDOMIZED

Intervention Model

SINGLE_GROUP

Primary Study Purpose

SUPPORTIVE_CARE

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

1

Dermacyd PH\_DETINBACK (Lactic Acid)

Group Type EXPERIMENTAL

Dermacyd PH_DETINBACK (Lactic Acid)

Intervention Type DRUG

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Dermacyd PH_DETINBACK (Lactic Acid)

Intervention Type DRUG

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

Phototype Skin I,II, III e IV

* Integral skin test in the region;
* Willingness in following the study procedures and to be present in the clinic at the days and scheduled time for medical evaluations and for application of occlusion;

Exclusion Criteria

* Lactation or gestation
* Use of Antiinflammatory and/or immunosuppression drugs
* Personnel history of atopy;
* History of sensitivity or irritation for topic products;
* Active cutaneous disease;
* Use of new drugs or cosmetics during the study

The above information is not intended to contain all considerations relevant to a patient's potential participation in a clinical trial.

Minimum Eligible Age

18 Years

Maximum Eligible Age

60 Years

Eligible Sex

FEMALE

Accepts Healthy Volunteers

Yes